Home / Our research / Northern Metabolic Bone Research Laboratory 

Dr Roderick Clifton-Bligh

Senior Lecturer
Medicine, Northern Clinical School
Kolling Institute of Medical Research

E25 - Royal North Shore Hospital
The University of Sydney
NSW 2006 Australia

T:02 99268388
F:02 99067525
E:

Research interests

Rory Clifton-Bligh is an endocrinologist with primary interests in thyroid cancer and metabolic bone disease research.

Back to Top

Publications

2009 | 2008 | 2006 | 2005 | 2004 | 2003

2009

  
  • Elston, M., McDonald, K., Clifton-Bligh, R., Robinson, B. Familial pituitary tumor syndromes. Nature reviews. Endocrinology. 2009; 5:453-61. [Abstract]
  • Meyer-Rochow, G., Soon, P., Delbridge, L., Sywak, M., Bambach, C., Clifton-Bligh, R., Robinson, B., Sidhu, S. Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ Journal of Surgery. 2009; 79:367-370. [Abstract]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. The Journal of clinical Endocrinology and Metabolism. 2009; 94:1436-1442. [Abstract]

2008

  
Back to Top
  • Tacon, L., Parkinson, J., Hudson, B., Brewer, J., Little, N., Clifton-Bligh, R. Headache of a diagnosis: frontotemporal pain and inflammation associated with osteolysis. The Medical Journal of Australia. 2008; 189:591-592. [Abstract]
  • Au, A., McDonald, K., Gill, A., Sywak, M., Diamond, T., Conigrave, A., Clifton-Bligh, R. PTH Mutation with Primary Hyperparathyroidism and Undetectable Intact PTH. The New England journal of medicine. 2008; 359:1184-1186. [Abstract]
  • Lee, J., Au, A., Foukakis, T., Barbaro, M., Kiss, N., Clifton-Bligh, R., Staaf, J., Borg, A., Delbridge, L., Robinson, B., Wallin, G., Höög, A., Larsson, C. Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocrine-related Cancer. 2008; 15:801-815. [Abstract]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Shaw, J., Law, A., Cook, R., Little, N., Clifton-Bligh, R., Robinson, B., McDonald, K. Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology. 2008; 149:1235-42. [Abstract]

2006

  
Back to Top
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone. 2006; 39:369-76. [Abstract]
  • Giordano, T., Au, A., Kuick, R., Thomas, D., Rhodes, D., Wilhelm, K., Vinco, M., Misek, D., Sanders, D., Zhu, Z., Ciampi, R., Hanash, S., Chinnaiyan, A., Clifton-Bligh, R., Robinson, B., Nikiforov, Y., Koenig, R. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical Cancer Research. 2006; 12:1983-1993. [Abstract]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. The Ras Effector NORE1A is Suppressed in Follicular Thyroid Carcinomas with a PAX8-PPAR{gamma} Fusion. The Journal of clinical endocrinology and metabolism. 2006; 91:1143-9. [Abstract]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR gamma fusion. Journal of Clinical Endocrinology and Metabolism. 2006; 91:1143-1149. [Abstract]
  • Au, A., McBride, C., Wilhelm, K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology. 2006; 147:367-76. [Abstract]

2005

  
Back to Top
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Nelson, A., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. Elevated serum FGF23 concentrations in plasma cell dyscrasias. Journal of Bone and Mineral Research. 2005; 20:S116-S116. [Abstract]
  • Mun, H., Culverston, E., Franks, A., Collyer, C., Clifton-Bligh, R., Conigrave, A. A double mutation in the extracellular Ca2+-sensing receptor's venus flytrap domain that selectively disables L-amino acid sensing. The Journal of biological chemistry. 2005; 280:29067-72. [Abstract]
  • Clifton-Bligh, R., Delbridge, L. Thyroid Physiology. In: Textbook of Endocrine Surgery. Philadelphia: Elsevier Saunders 2005. p. 3-8.

2004

  
Back to Top
  • Veitch, P., Clifton-Bligh, R. Long-acting sulfonylureas -- long-acting hypoglycaemia. The Medical journal of Australia. 2004; 180:84-5. [Abstract]

2003

  
Back to Top
  • Nelson, A., Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jüppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., Bligh, P. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. The Journal of clinical endocrinology and metabolism. 2003; 88:4088-4094. [Abstract]
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. The Journal of clinical endocrinology and metabolism. 2003; 88:354-7. [Abstract]